Comparative Evaluation of the Tolerability of Cefazolin and Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections in the Outpatient Setting | Zendy

Ilan Youngster | Zendy; Erica S. Shenoy | Zendy; David C. Hooper | Zendy; Sacha B. Nelson | Zendy

Open Access

Comparative Evaluation of the Tolerability of Cefazolin and Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections in the Outpatient Setting

Author(s) -

Ilan Youngster,

Erica S. Shenoy,

David C. Hooper,

Sacha B. Nelson

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu301

Subject(s) - nafcillin , cefazolin , medicine , discontinuation , tolerability , interquartile range , retrospective cohort study , surgery , antibacterial agent , anesthesia , antibiotics , adverse effect , penicillin , microbiology and biotechnology , biology

Nafcillin and cefazolin are considered first-line therapy for most infections with methicillin-susceptible Staphylococcus aureus (MSSA), and recent studies have suggested similar clinical efficacy. Limited data are available on the comparative tolerability of these agents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research